FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:836-841 March 19, 1998 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Lurie, P. Related Article by Varmus, H. PubMed Citation

To the Editor: Lurie and Wolfe (Sept. 18 issue)¹ claim that ongoing placebo-controlled trials of antiretroviral agents to reduce perinatal transmission of the human immunodeficiency virus (HIV) in developing countries are unethical. As executive director of the World Health Organization Global Program on AIDS, I convened the June 1994 meeting that considered how best to apply the impressive results of AIDS Clinical Trials Group (ACTG) study 076 in developing countries, where 90 percent of HIV infections occur. Twenty-eight experts from eight developed and six developing countries participated.

Contrary to the accusations of Lurie and Wolfe, the only relevant information known . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Lynoe, N., Sandlund, M., Jacobsson, L., Nordberg, G., Jin, T. (2004). Informed consent in China: quality of information provided to participants in a research project. Scand J Public Health 32: 472-475 [Abstract]  
• Angell, M. (2000). Investigators' Responsibilities for Human Subjects in Developing Countries. NEJM 342: 967-969 [Full Text]